ENSG00000008311


Homo sapiens

Features
Gene ID: ENSG00000008311
  
Biological name :AASS
  
Synonyms : AASS / aminoadipate-semialdehyde synthase / Q9UDR5
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 7
Strand: -1
Band: q31.32
Gene start: 122075647
Gene end: 122144280
  
Corresponding Affymetrix probe sets: 210852_s_at (Human Genome U133 Plus 2.0 Array)   214829_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000394180
Ensembl peptide - ENSP00000414001
Ensembl peptide - ENSP00000403768
Ensembl peptide - ENSP00000351834
Ensembl peptide - ENSP00000377040
NCBI entrez gene - 10157     See in Manteia.
OMIM - 605113
RefSeq - NM_005763
RefSeq - XM_011515725
RefSeq Peptide - NP_005754
swissprot - Q9UDR5
swissprot - H7C0C6
swissprot - F8WAH1
swissprot - F8WE53
swissprot - A4D0W4
Ensembl - ENSG00000008311
  
Related genetic diseases (OMIM): 238700 - Hyperlysinemia, 238700
  268700 - Saccharopinuria, 268700
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 aassENSDARG00000051816Danio rerio
 AASSENSGALG00000008953Gallus gallus
 AassENSMUSG00000029695Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
No match


Protein motifs (from Interpro)
Interpro ID Name
 IPR005097  Saccharopine dehydrogenase, NADP binding domain
 IPR007698  Alanine dehydrogenase/pyridine nucleotide transhydrogenase, NAD(H)-binding domain
 IPR007886  Alanine dehydrogenase/pyridine nucleotide transhydrogenase, N-terminal
 IPR032095  Saccharopine dehydrogenase, C-terminal
 IPR036291  NAD(P)-binding domain superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0006091 generation of precursor metabolites and energy IBA
 biological_processGO:0006554 lysine catabolic process NAS
 biological_processGO:0008152 metabolic process IEA
 biological_processGO:0019477 L-lysine catabolic process IEA
 biological_processGO:0019878 lysine biosynthetic process via aminoadipic acid IBA
 biological_processGO:0033512 L-lysine catabolic process to acetyl-CoA via saccharopine IEA
 biological_processGO:0051262 protein tetramerization TAS
 biological_processGO:0055114 oxidation-reduction process IEA
 cellular_componentGO:0005739 mitochondrion TAS
 cellular_componentGO:0005759 mitochondrial matrix TAS
 cellular_componentGO:0043231 intracellular membrane-bounded organelle IDA
 molecular_functionGO:0003824 catalytic activity IEA
 molecular_functionGO:0004753 saccharopine dehydrogenase activity IBA
 molecular_functionGO:0016491 oxidoreductase activity IEA
 molecular_functionGO:0047130 saccharopine dehydrogenase (NADP+, L-lysine-forming) activity EXP
 molecular_functionGO:0047131 saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity EXP


Pathways (from Reactome)
Pathway description
Lysine catabolism


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0000119 Genitourinary abnormality "The presence of any abnormality of the genitourinary system." [HPO:curators]
Show

 HP:0000736 Short attention span "Reduced attention span characterized by distractibility and impulsivity but not necessarily satisfying the diagnostic criteria for attention deficit hyperactivity disorder." [HPO:curators]
Show

 HP:0000750 Impaired language development 
Show

 HP:0000752 Hyperactivity 
Show

 HP:0001083 Ectopia lentis 
Show

 HP:0001249 Mental retardation 
Show

 HP:0001250 Seizures "Seizures are an intermittent `abnormality of the central nervous system` (FMA:HP:0002011) due to a sudden, excessive, disorderly discharge of cerebral neurons and characterized clinically by some combination of disturbance of sensation, loss of consciousness, impairment of psychic function, or convulsive movements." [HPO:probinson]
Show

 HP:0001252 Muscular hypotonia "Muscular hypotonia is an abnormally low muscle tone (the amount of tension or resistance to movement in a muscle), often involving reduced muscle strength. Hypotonia is characterized by a diminished resistance to passive stretching." [HPO:curators]
Show

 HP:0001256 Mental retardation, mild "Mild mental retardation is defined as an intelligence quotient (IQ) in the range of 50-69." [HPO:curators]
Show

 HP:0001264 Spastic diplegia "Spasticity (neuromuscular hypertonia) primarily in the muscles of the legs, hips, and pelvis." [HPO:curators]
Show

 HP:0001903 Anemia 
Show

 HP:0002161 Hyperlysinemia 
Show

 HP:0002353 EEG abnormalities "Abnormality observed by electroencephalogram (EEG), which is used to record of the brain s spontaneous electrical activity from multiple electrodes placed on the scalp." [HPO:curators]
Show

 HP:0002927 Histidinuria 
Show

 HP:0003297 Hyperlysinuria 
Show

 HP:0003593 Early onset 
Show

 HP:0003812 Phenotypic variability 
Show

 HP:0004322 Decreased body height "A height below that which is expected according to age and gender norms. Although there is no universally accepted definition of short stature, many refer to "short stature" as height more than 2 standard deviations below the mean for age and gender (or below the 3rd percentile for age and gender dependent norms)." [HPO:curators]
Show

 HP:0100543 Cognitive impairment "Abnormality in the process of thought including the ability to process information." [HPO:sdoelken]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000008311 AASS / Q9UDR5 / aminoadipate-semialdehyde synthase  / complex






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr